InsidersTradesSigma
Track the 온코닉테라퓨틱스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 온코닉테라퓨틱스 has logged 6 reports. Market capitalisation: €504.5bn. The latest transaction was filed on 12 June 2026 (Sale). Among the most active insiders: 김정훈. All data is free.
6
Insider Decl.
n/a
Thresholds
€587,929
3 ops.
Buy Volume
€257,169
2 ops.
Sell Volume
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,837 of 29,065 companies
63.0
score / 100
Value31
Quality95
FCF yld1.4%
Earn yld2.0%
EV/EBITDA56.7x
ROE29%
Gross mgn100%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 June 2026
Declarations6 total
6 of 6 declarations
About 온코닉테라퓨틱스
Onconic Therapeutics is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative treatments for serious diseases.